Q fever in pregnancy

Journal of Infection

Volumn 34, Issue 1, 1997, Pages 75-78

  Ludlam, H ^a   Wreghitt, T G ^a   Thornton, S ^a   Thomson, B J ^a   Bishop, N J ^a   Coomber, S ^a   Cunniffe, J ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; COXIELLA BURNETII; FEMALE; HUMAN; INFECTION CONTROL; ORAL DRUG ADMINISTRATION; PREGNANCY; Q FEVER; SECOND TRIMESTER PREGNANCY; SYMPTOM; VERTICAL TRANSMISSION;

EID: 0031053625     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)80014-X     Document Type: Article

References (18)

1. Friedland JS, Jeffrey I, Griffin GE, Booker M, Courtenay-Evans R. Q fever and intrauterine death. Lancet 1994; 343: 288.
2. Raoult D, Stein A, Q fever during pregnancy - a risk for women, fetuses, and obstetricians. N Engl J Med 1994; 330: 371.
3. Marrie TJ. Q fever in pregnancy: report of two cases. Infect Dis Clin Pract 1993; 2: 207-209.
4. Reimer LG. Q fever. Clin Microbiol Rev 1993; 6: 193-198.
5. Yeaman MR, Mitscher LA, Baca OG. In vitro susceptibility of Coxiela burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother 1987; 31: 1079-1084.
6. Yebra M, Ortigosa J, Albarran F, Crespo MG. Ciprofloxacin in a case of Q fever endocarditis. N Engl J Med 1990; 323: 614.
7. Raoult D, Gallais H, De Micco P, Casanova P, Ciprofloxacin therapy for mediterranean spotted fever. Antimicrob Agents Chemother 1986; 30: 606-607.
8. Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994; 84: 535-538.
9. Reichman N, Raz R, Keysary A, Goldwasser R, Flatau E. Chronic Q fever and severe thrombocytopenia in a pregnant woman. Am J Med 1988; 85: 253-254.
10. Keren G, Keysary A, Goldwasser R, Rubinstein E. The inhibitory effect of flouroquinolones on Coxiella burnetii growth in in-vitro systems. J Antimicrob Chemother 1994; 33: 1254-1255.
11. Yeaman MR, Roman MJ, Baca OG. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Antimicrob Agents Chemother 1989; 33: 1052-1057.
12. Levy PY, Drancourt M, Etienne J et al. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother 1991; 35: 533-537.
13. Marrie TJ. Coxiella burnetii (Q fever). In: Mandell GL, Gordon Douglas R, Bennett JE, Eds. Principles and Practice of Infectious Diseases. 3rd Edn. New York: Churchill Livingstone, 1990; 1472-1476.
14. Centres for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities, 1994. MMWR Morb Mortal Wkly Rep, Recommendations and Reports. 1994; 43, No. RR-13.
15. Adal KA, Anglim AM, Palumbo CL, Titus MG, Coyner BJ, Farr BM. The use of high-efficiency particulate air-filter respirators to protect hospital workers from tuberculosis. N Engl J Med 1994; 331: 169-173.
16. Department of Health and Central Office of Information, 1991. While you are pregnant: safe eating and how to avoid infection from food and animals.
17. Laughlin T, Waag D, Williams J, Marrie T. Q fever: from deer to dog to man. Lancet 1991; 337: 676-677.
18. Marrie TJ, Durant H, Williams JC, Mintz E, Waag DM. Exposure to parturient cats: a risk factor for acquisition of Q fever in Maritime Canada. J Infect Dis 1988; 158: 101-108.